ERYKINE 40000 INJ
Out of Stock
ERYKINE 40000 IU INJECTION by Intas Pharmaceuticals Ltd. is a veterinary-applicable erythropoiesis-stimulating injectable therapy designed to manage anemia associated with chronic kidney disease, chemotherapy, or other conditions causing reduced red blood cell production. This advanced biologic formulation targets low hemoglobin levels by stimulating erythropoiesis (red blood cell formation), helping restore oxygen-carrying capacity and improving vitality in your canine companion or feline patient under veterinary supervision. Its recombinant protein technology makes it a cutting-edge supportive therapy in clinical anemia management. Animeal is proud to offer this clinically trusted hematinic therapy as part of its specialized veterinary pharmacy range.
Ingredients:
Recombinant Human Erythropoietin Alfa (Epoetin Alfa) 40,000 IU per 1 ml:
Epoetin alfa is a recombinant glycoprotein biologic that mimics endogenous erythropoietin, a hormone naturally produced by the kidneys. At the cellular level, it binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow, activating JAK2/STAT signaling pathways that promote proliferation and differentiation into mature red blood cells. This results in increased hemoglobin synthesis and improved tissue oxygenation, thereby addressing anemia-related fatigue and weakness.
Buffering Agents and Stabilizing Excipients q.s.:
These pharmaceutical excipients maintain protein stability, isotonicity, and pH balance to preserve biologic activity. They help prevent protein denaturation and ensure safe parenteral administration.
Water for Injection q.s.:
Sterile water serves as the vehicle for safe delivery of the biologic agent, ensuring compatibility with subcutaneous or intravenous administration protocols.
